2 Healthcare Stocks That Will Be Worth More Than Pfizer by the End of 2026
Pfizer‘s (NYSE: PFE) shares have been southbound for the last three years. And unfortunately for the company, it…
Should You Buy Pfizer While It’s Under $30?
Pfizer has been struggling for several years. The company’s pipeline could help it turn things around. It also…
Where Will Pfizer Be in 5 Years?
Pfizer’s stock soared during the coronavirus pandemic because of its COVID-19 vaccine. The world has learned to live…
Drugmakers to raise US prices on 350 medicines despite pressure from President Trump
Drugmakers plan to raise US prices on at least 350 branded medications including vaccines against COVID, RSV and shingles…
Better Buy in 2026: Pfizer or Eli Lilly?
Eli Lilly has been a dominant force in the GLP-1 market, and that looks set to continue. Pfizer’s…
Forget Teladoc and Buy This Healthcare Stock Instead
Telemedicine leader Teladoc Health (NYSE: TDOC) has been struggling for several years. The company’s services are no longer experiencing…
TERREPOWER Promotes Dallas-Based VP to Chief People Officer » Dallas Innovates
Jason Beck, COO of TERREPOWER. [Composite image; source: Valor/DI Studio] Alabama-based TERREPOWER, which specializes in providing high-quality components…
Do These 3 Healthcare Stocks Need a Checkup?
Pfizer has a sizable 6.8% yield and is down nearly 60% from its 2021 highs. Bristol Myers Squibb…
Which Healthcare Giant Is the Better Bet?
Novo Nordisk NVO and Pfizer PFE are pharmaceutical giants based in Denmark and the United States, respectively, with strong…
U.S. Negotiates Lower Prices for Ozempic and 14 Other Drugs
The U.S. government negotiated lower prices in the federal Medicare program for 15 high-selling medicines including Ozempic, widening…